Estrogens maintain bone mass by regulating expression of genes controlling function and life span in mature osteoclasts

Yuuki Imai, Ming Young Youn, Shino Kondoh, Takashi Nakamura, Alexander Kouzmenko, Takahiro Matsumoto, Ichiro Takada, Kunio Takaoka, Shigeaki Kato

Research output: Contribution to journalReview article

61 Citations (Scopus)

Abstract

Estrogens play a key role in regulation of bone mass and strength by controlling activity of bone-forming osteoblasts and bone-resorbing osteoclasts. Cellular effects of estrogens are mediated predominantly by the action of estrogen receptor alpha (ERα). In earlier studies, ablation of the ERα gene in mice did not result in osteoporotic phenotypes due to systemic endocrine disturbance and compensatory effects of elevated levels of testosterone. Despite the relatively well-established effects in osteoblasts, little is known about the direct action of estrogen in osteoclasts. Development in the last decade of more sophisticated genetic manipulation approaches opened new possibilities to explore cell-specific roles of nuclear receptors in bone tissue. Recently, we have generated osteoclast-specific ERα gene knockout mice and shown that in vivo estrogens directly regulate the life span of mature osteoclasts by inducing the expression of pro-apoptotic Fas ligand (FasL). Inhibitory effects of estrogens on osteoclast function were further studied in vitro. We observed sufficiently detectable ERα expression in osteoclasts differentiating from primary bone marrow cells or RAW264 cells, although levels of ERα were decreasing during progression of the differentiation into mature osteoclasts. Treatment with estrogens led to reduction in expression of osteoclast-specific genes controlling bone resorption activity. However, estrogens did not affect the size of multinucleated osteoclasts or number of nuclei in a mature osteoclast. In conclusion, in osteoclasts, estrogens function to inhibit bone resorption activity and vitality rather than differentiation.

Original languageEnglish
JournalAnnals of the New York Academy of Sciences
Volume1173
Issue numberSUPPL. 1
DOIs
Publication statusPublished - 2009 Sep
Externally publishedYes

Fingerprint

Osteoclasts
Bone
Estrogens
Genes
Gene Expression
Bone and Bones
Estrogen Receptor alpha
Osteoblasts
Bone Resorption
Gene
Estrogen
Life Span
Gene Knockout Techniques
Fas Ligand Protein
Cytoplasmic and Nuclear Receptors
Ablation
Knockout Mice
Bone Marrow Cells
Testosterone
Cells

Keywords

  • bone
  • estrogen receptor
  • osteoclast

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Estrogens maintain bone mass by regulating expression of genes controlling function and life span in mature osteoclasts. / Imai, Yuuki; Youn, Ming Young; Kondoh, Shino; Nakamura, Takashi; Kouzmenko, Alexander; Matsumoto, Takahiro; Takada, Ichiro; Takaoka, Kunio; Kato, Shigeaki.

In: Annals of the New York Academy of Sciences, Vol. 1173, No. SUPPL. 1, 09.2009.

Research output: Contribution to journalReview article

Imai, Y, Youn, MY, Kondoh, S, Nakamura, T, Kouzmenko, A, Matsumoto, T, Takada, I, Takaoka, K & Kato, S 2009, 'Estrogens maintain bone mass by regulating expression of genes controlling function and life span in mature osteoclasts', Annals of the New York Academy of Sciences, vol. 1173, no. SUPPL. 1. https://doi.org/10.1111/j.1749-6632.2009.04954.x
Imai, Yuuki ; Youn, Ming Young ; Kondoh, Shino ; Nakamura, Takashi ; Kouzmenko, Alexander ; Matsumoto, Takahiro ; Takada, Ichiro ; Takaoka, Kunio ; Kato, Shigeaki. / Estrogens maintain bone mass by regulating expression of genes controlling function and life span in mature osteoclasts. In: Annals of the New York Academy of Sciences. 2009 ; Vol. 1173, No. SUPPL. 1.
@article{c66fe656f4504d37bd29867421b0e7ab,
title = "Estrogens maintain bone mass by regulating expression of genes controlling function and life span in mature osteoclasts",
abstract = "Estrogens play a key role in regulation of bone mass and strength by controlling activity of bone-forming osteoblasts and bone-resorbing osteoclasts. Cellular effects of estrogens are mediated predominantly by the action of estrogen receptor alpha (ERα). In earlier studies, ablation of the ERα gene in mice did not result in osteoporotic phenotypes due to systemic endocrine disturbance and compensatory effects of elevated levels of testosterone. Despite the relatively well-established effects in osteoblasts, little is known about the direct action of estrogen in osteoclasts. Development in the last decade of more sophisticated genetic manipulation approaches opened new possibilities to explore cell-specific roles of nuclear receptors in bone tissue. Recently, we have generated osteoclast-specific ERα gene knockout mice and shown that in vivo estrogens directly regulate the life span of mature osteoclasts by inducing the expression of pro-apoptotic Fas ligand (FasL). Inhibitory effects of estrogens on osteoclast function were further studied in vitro. We observed sufficiently detectable ERα expression in osteoclasts differentiating from primary bone marrow cells or RAW264 cells, although levels of ERα were decreasing during progression of the differentiation into mature osteoclasts. Treatment with estrogens led to reduction in expression of osteoclast-specific genes controlling bone resorption activity. However, estrogens did not affect the size of multinucleated osteoclasts or number of nuclei in a mature osteoclast. In conclusion, in osteoclasts, estrogens function to inhibit bone resorption activity and vitality rather than differentiation.",
keywords = "bone, estrogen receptor, osteoclast",
author = "Yuuki Imai and Youn, {Ming Young} and Shino Kondoh and Takashi Nakamura and Alexander Kouzmenko and Takahiro Matsumoto and Ichiro Takada and Kunio Takaoka and Shigeaki Kato",
year = "2009",
month = "9",
doi = "10.1111/j.1749-6632.2009.04954.x",
language = "English",
volume = "1173",
journal = "Annals of the New York Academy of Sciences",
issn = "0077-8923",
publisher = "Wiley-Blackwell",
number = "SUPPL. 1",

}

TY - JOUR

T1 - Estrogens maintain bone mass by regulating expression of genes controlling function and life span in mature osteoclasts

AU - Imai, Yuuki

AU - Youn, Ming Young

AU - Kondoh, Shino

AU - Nakamura, Takashi

AU - Kouzmenko, Alexander

AU - Matsumoto, Takahiro

AU - Takada, Ichiro

AU - Takaoka, Kunio

AU - Kato, Shigeaki

PY - 2009/9

Y1 - 2009/9

N2 - Estrogens play a key role in regulation of bone mass and strength by controlling activity of bone-forming osteoblasts and bone-resorbing osteoclasts. Cellular effects of estrogens are mediated predominantly by the action of estrogen receptor alpha (ERα). In earlier studies, ablation of the ERα gene in mice did not result in osteoporotic phenotypes due to systemic endocrine disturbance and compensatory effects of elevated levels of testosterone. Despite the relatively well-established effects in osteoblasts, little is known about the direct action of estrogen in osteoclasts. Development in the last decade of more sophisticated genetic manipulation approaches opened new possibilities to explore cell-specific roles of nuclear receptors in bone tissue. Recently, we have generated osteoclast-specific ERα gene knockout mice and shown that in vivo estrogens directly regulate the life span of mature osteoclasts by inducing the expression of pro-apoptotic Fas ligand (FasL). Inhibitory effects of estrogens on osteoclast function were further studied in vitro. We observed sufficiently detectable ERα expression in osteoclasts differentiating from primary bone marrow cells or RAW264 cells, although levels of ERα were decreasing during progression of the differentiation into mature osteoclasts. Treatment with estrogens led to reduction in expression of osteoclast-specific genes controlling bone resorption activity. However, estrogens did not affect the size of multinucleated osteoclasts or number of nuclei in a mature osteoclast. In conclusion, in osteoclasts, estrogens function to inhibit bone resorption activity and vitality rather than differentiation.

AB - Estrogens play a key role in regulation of bone mass and strength by controlling activity of bone-forming osteoblasts and bone-resorbing osteoclasts. Cellular effects of estrogens are mediated predominantly by the action of estrogen receptor alpha (ERα). In earlier studies, ablation of the ERα gene in mice did not result in osteoporotic phenotypes due to systemic endocrine disturbance and compensatory effects of elevated levels of testosterone. Despite the relatively well-established effects in osteoblasts, little is known about the direct action of estrogen in osteoclasts. Development in the last decade of more sophisticated genetic manipulation approaches opened new possibilities to explore cell-specific roles of nuclear receptors in bone tissue. Recently, we have generated osteoclast-specific ERα gene knockout mice and shown that in vivo estrogens directly regulate the life span of mature osteoclasts by inducing the expression of pro-apoptotic Fas ligand (FasL). Inhibitory effects of estrogens on osteoclast function were further studied in vitro. We observed sufficiently detectable ERα expression in osteoclasts differentiating from primary bone marrow cells or RAW264 cells, although levels of ERα were decreasing during progression of the differentiation into mature osteoclasts. Treatment with estrogens led to reduction in expression of osteoclast-specific genes controlling bone resorption activity. However, estrogens did not affect the size of multinucleated osteoclasts or number of nuclei in a mature osteoclast. In conclusion, in osteoclasts, estrogens function to inhibit bone resorption activity and vitality rather than differentiation.

KW - bone

KW - estrogen receptor

KW - osteoclast

UR - http://www.scopus.com/inward/record.url?scp=70350452037&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70350452037&partnerID=8YFLogxK

U2 - 10.1111/j.1749-6632.2009.04954.x

DO - 10.1111/j.1749-6632.2009.04954.x

M3 - Review article

C2 - 19751412

AN - SCOPUS:70350452037

VL - 1173

JO - Annals of the New York Academy of Sciences

JF - Annals of the New York Academy of Sciences

SN - 0077-8923

IS - SUPPL. 1

ER -